MGAT5B

Across TCGA pan-cancer cohorts, MGAT5B mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MGAT5B data layer compared with 23 for mass-spec protein and 9 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher MGAT5B mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated MGAT5B expression acts as an unfavorable survival marker.

CCRCC are the cancer types where MGAT5B mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Tertile	All	0.597	0.909	.005	19	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

MGAT5B–CCRCC (DFS)

Open the CCRCC breakdown →